PATENT CLAIM ANALYSIS

Application Number: 15892070
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-06
Patent Classification: ["514", "014700"]

Abstract:
The present invention is directed to the following: methods of treating or preventing stent thrombosis using pharmaceutical compositions comprising cangrelor and optionally bivalirudin; methods of reducing mortality in a subject undergoing stent implantation using pharmaceutical compositions comprising cangrelor and optionally bivalirudin; medicaments comprising cangrelor and optionally bivalirudin useful for treating or preventing stent thrombosis, or useful for reducing mortality in a subject undergoing stent implantation; pharmaceutical compositions comprising cangrelor and bivalirudin; and methods of preparing a medicament comprising cangrelor and optionally bivalirudin useful for treating or preventing stent thrombosis, or useful for reducing mortality in a subject undergoing stent implantation.

Claim (Index 6):
The method of  claim 5 , wherein the pharmaceutical composition further comprises bivalirudin.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 88.0
- Lexical Diversity: 2.76923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12943717', '14050266', '13792056', '13904778', '15643745']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.811819968122954
- 35 USC 102 Novelty (BERT): 0.6905943396330824
- Combined Prediction Score: 0.7996974052739668
- Mean Citation Score: 531.274086
- Max Citation Score: 706.35596
- Similarity Product: 700.2542716233968

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test